In a significant advance in diabetes treatment, drugmaker Eli Lilly said today that its experimental pill, orforglippon, produced dramatic results in a late-stage study — bringing new hope to millions of type 2 diabetes and obesity patients. The drug, a once-daily tablet, is in the GLP-1 receptor agonist class — the same family as injectable […]
Pfizer Stock Falls After Halting Weight-Loss Drug Trial Over Safety Concerns
Pfizer’s stock has had a rough ride lately, and honestly, it’s left investors scratching their heads. As of April 14, 2025, shares are hovering around $22.18—a far cry from the high-flying days of the pandemic. But here’s the thing: this latest dip isn’t just about market jitters or macroeconomic headwinds. It’s about another blow to […]
NEWS179 brings you the latest news and top breaking headlines on politics, current affairs, entertainment, and more.
